Cardiovascular Manifestations of Patients with Long COVID

Gordana Krljanac1,2, Milika Asanin1,2, Mihajlo Viduljevic1

  • 1Clinic of Cardiology, University Clinical Centre of Serbia, 11000 Belgrade, Serbia.

Insights

Long COVID frequently causes heart problems, including inflammation-driven structural and functional changes. Multimodality imaging helps detect these cardiovascular issues for timely treatment.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Medical Imaging

Background:

  • Long COVID, a condition following SARS-CoV-2 infection, presents with persistent symptoms impacting various organ systems.
  • Cardiovascular manifestations are increasingly recognized as a significant sequela of long COVID.
  • Understanding the underlying mechanisms of cardiac involvement is crucial for patient management.

Purpose of the Study:

  • To investigate the mechanisms of cardiac structural and functional changes in patients with long COVID.
  • To identify cardiovascular phenotypes associated with long COVID.
  • To assess the utility of multimodality imaging in characterizing cardiac involvement.

Main Methods:

  • Study included 176 outpatients with long COVID symptoms exceeding 12 weeks.
  • Echocardiography was performed to assess left ventricular ejection fraction (LVEF) and myocardial strain (longitudinal and circumferential).
  • Cardiac magnetic resonance (CMR) imaging, including late gadolinium enhancement (LGE) and T1/T2 mapping, was utilized to evaluate cardiac pathology.

Main Results:

  • Patients with long COVID and cardiovascular manifestations experienced higher hospitalization rates and longer stays.
  • Significant echocardiography findings included reduced LVEF, impaired longitudinal and circumferential strain, and altered CS PSS.
  • CMR revealed pathological findings in 58.2% of patients, with prevalent LGE, elevated native T1, and elevated native T2 mapping.

Conclusions:

  • Long COVID frequently leads to cardiovascular structural and functional alterations, predominantly due to persistent inflammation.
  • Multimodality imaging is essential for identifying mechanisms, predicting conditions like chronic myocarditis and early heart failure.
  • Early recognition of cardiovascular phenotypes in long COVID is critical for effective and timely therapeutic interventions.

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
35
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
48
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
23
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
59
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
25
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
47